| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sangamo Therapeutics, Inc (SGMO) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. SGMO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.91M | $193.1K | - | |
| Other | 696.7K | $70.5K | - | |
| VP | 678.7K | $68.7K | - | |
| VP | 651.4K | $65.9K | - | |
| Other | 237.2K | $24.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2020 | Zakrzewski Joseph S55 | Director | Buy | 20,000 | $6.15 | $123,000.00 | +80.0% | |
| May 15, 2019 | Yi Kathy | EVP &Chief Financial Officer | Sale+OE | 5,000 | $10.00 | $50,000.00 | -16.4% | |
| Apr 15, 2019 | Yi Kathy | EVP &Chief Financial Officer | Sale+OE | 5,000 | $12.11 | $60,550.00 | -16.4% | |
| Mar 15, 2019 | Yi Kathy | EVP &Chief Financial Officer | Sale+OE | 5,000 | $10.00 | $50,000.00 | -16.4% | |
| Mar 1, 2019 | Yi Kathy | EVP &Chief Financial Officer | Sale+OE | 5,000 | $10.00 | $50,000.00 | -16.4% | |
| Jan 15, 2019 | Yi Kathy | SVP &Chief Financial Officer | Sale+OE | 5,000 | $11.04 | $55,200.00 | -40.8% | |
| Jan 7, 2019 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $12.33 | $61,630.50 | -29.2% | |
| Dec 17, 2018 | Yi Kathy | SVP &Chief Financial Officer | Sale+OE | 5,000 | $11.44 | $57,200.00 | -40.8% | |
| Dec 6, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $11.49 | $57,433.00 | -29.2% | |
| Nov 15, 2018 | Yi Kathy | SVP &Chief Financial Officer | Sale+OE | 5,000 | $10.00 | $50,000.00 | -40.8% |